Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016 (2016), Article ID 6035024, 7 pages
http://dx.doi.org/10.1155/2016/6035024
Research Article

Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Bulent Ecevit University, 67600 Zonguldak, Turkey
2Department of Internal Medicine, Faculty of Medicine, Bulent Ecevit University, 67600 Zonguldak, Turkey
3Department of Biochemistry, Faculty of Medicine, Bulent Ecevit University, 67600 Zonguldak, Turkey
4Department of Pathology, Faculty of Medicine, Bulent Ecevit University, 67600 Zonguldak, Turkey
5Department of Biostatistics, Faculty of Medicine, Bulent Ecevit University, 67600 Zonguldak, Turkey

Received 21 March 2016; Accepted 3 May 2016

Academic Editor: Diego Russo

Copyright © 2016 Fatih Kuzu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fatih Kuzu, Dilek Arpaci, Mustafa Unal, et al., “Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease,” International Journal of Endocrinology, vol. 2016, Article ID 6035024, 7 pages, 2016. doi:10.1155/2016/6035024